Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 15 May 2023

A retrospective study of autologous hematopoietic stem cell transplantation for peripheral T-cell lymphoma: pre-transplant patients with partial remission benefit from post-transplant maintenance therapy

in Hematologic Malignancies

Zhenghua Huang
Zhen Li
Juan Wang
Ruirui Gui
Yingling Zu
Fengkuan Yu
Quande Lin
Huifang Zhao
Yanli Zhang
Baijun Fang

Frontiers in Oncology

doi 10.3389/fonc.2023.1162413

2,766 views
2 citations

Review

Published on 12 May 2023

Clinical considerations at the intersection of hematopoietic cell transplantation and hereditary hematopoietic malignancy

in Hematologic Malignancies

Timothy E. O’Connor
Reid Shaw
Rafael Madero-Marroquin
Gregory W. Roloff

Frontiers in Oncology

doi 10.3389/fonc.2023.1180439

2,853 views
5 citations

Brief Research Report

Published on 12 May 2023

Intragenic β-synuclein rearrangements in malignancy

in Hematologic Malignancies

Peifang Xiao
Nan Chen
Tingting Shao
Xinni Bian
Jie Miao
Jiajia Zheng
Xingping Lang
Yiting Wang
Xiaojun Chen
Liqin Jin

Frontiers in Oncology

doi 10.3389/fonc.2023.1167143

3,838 views
1 citation

Original Research

Published on 12 May 2023

Primary blastic plasmacytoid dendritic cell neoplasm: a US population-based study

in Hematologic Malignancies

Lifang Huang
Fan Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1178147

3,581 views
4 citations

Editorial

Published on 10 May 2023

Editorial: Acute leukemias: molecular characterization, leukemia-initiating cells, and influence of the microenvironment

in Hematologic Malignancies

Garrett M. Dancik
Lokman Varisli
Ioannis F. Voutsas
Spiros Vlahopoulos

Frontiers in Oncology

doi 10.3389/fonc.2023.1199354

1,726 views
2 citations

Editorial

Published on 10 May 2023

Editorial: Measurable residual disease in hematologic malignancies

in Hematologic Malignancies

Francesco Buccisano
Raffaele Palmieri
Monica L. Guzman
Sara Galimberti

Frontiers in Oncology

doi 10.3389/fonc.2023.1204393

2,198 views

Original Research

Published on 10 May 2023

Effects of isolated central nervous system involvement evaluated by multiparameter flow cytometry prior to allografting on outcomes of patients with acute lymphoblastic leukemia

in Hematologic Malignancies

Ling Ma
Lan-Ping Xu
Yu Wang
Xiao-Hui Zhang
Huan Chen
Yu-Hong Chen
Feng-Rong Wang
Wei Han
Yu-Qian Sun
Chen-Hua Yan

Frontiers in Oncology

doi 10.3389/fonc.2023.1166990

2,574 views

Original Research

Published on 09 May 2023

Preclinical investigations of the efficacy of the glutaminase inhibitor CB-839 alone and in combinations in chronic lymphocytic leukemia

in Hematologic Malignancies

Natalia Timofeeva
Mary L. Ayres
Natalia Baran
Janice M. Santiago-O’Farrill
Gamze Bildik
Zhen Lu
Marina Konopleva
Varsha Gandhi

Frontiers in Oncology

doi 10.3389/fonc.2023.1161254

8,333 views
24 citations

Review

Published on 09 May 2023

Liquid biopsies and minimal residual disease in lymphoid malignancies

in Hematologic Malignancies

Maroun Bou Zerdan
Joseph Kassab
Ludovic Saba
Elio Haroun
Morgan Bou Zerdan
Sabine Allam
Lewis Nasr
Walid Macaron
Mahinbanu Mammadli
Sarah Abou Moussa

Frontiers in Oncology

doi 10.3389/fonc.2023.1173701

6,667 views
7 citations

Original Research

Published on 09 May 2023

Gene mutation landscape of a rare patient with acute megakaryoblastic leukemia after treatment of intracranial germ cell tumor

in Hematologic Malignancies

Li-Xin Wang
Wei-Jie Liao
Yu-Hua Jiang
Chao Chen
Wang-Sheng Lu
Feng Yin
Hao-Yong Ning

Frontiers in Oncology

doi 10.3389/fonc.2023.1093434

2,097 views

Review

Published on 08 May 2023

The role of androgen therapy in acquired aplastic anemia and other bone marrow failure syndromes

in Hematologic Malignancies

Momen Nassani
Riad El Fakih
Jakob Passweg
Simone Cesaro
Hazzaa Alzahrani
Ali Alahmari
Carmem Bonfim
Raheel Iftikhar
Amal Albeihany
Constantijn Halkes

Frontiers in Oncology

doi 10.3389/fonc.2023.1135160

9,475 views
11 citations

Original Research

Published on 08 May 2023

Exploring preferences of different modes of administration of hypomethylating agent treatments among patients with acute myeloid leukemia

in Hematologic Malignancies

Audrey Delmas
Laurie Batchelder
Ira Arora
Solene Bayet
David Bruhn
Alice Eberhardt
Stephanie Philpott
Ana Maria Rodriguez-Leboeuf

Frontiers in Oncology

doi 10.3389/fonc.2023.1160966

4,426 views
4 citations

Case Report

Published on 08 May 2023

Case Report: First longitudinal study of a patient with CALR positive clonal hematopoiesis of indeterminate potential developing into pre-fibrotic myelofibrosis

in Hematologic Malignancies

Lasse Kjær
Vibe Skov
Morten Kranker Larsen
Tobias Idor Boklund
Morten Andersen
Maria Kefala
Trine A. Knudsen
Christina Schjellerup Eickhardt-Dalbøge
Thomas Stiehl
Johanne Gudmand-Høyer

Frontiers in Oncology

doi 10.3389/fonc.2023.1176173

4,138 views
3 citations

Original Research

Published on 05 May 2023

Radiation doses to mediastinal organs at risk in early-stage unfavorable Hodgkin lymphoma– a risk stratified analysis of the GHSG HD17 trial

in Hematologic Malignancies

Michael Oertel
Dominik Hering
Christian Baues
Christopher Kittel
Michael Fuchs
Jan Kriz
Kai Kröger
Dirk Vordermark
Klaus Herfarth
Rita Engenhart-Cabillic

Frontiers in Oncology

doi 10.3389/fonc.2023.1183906

4,755 views
6 citations

Review

Published on 05 May 2023

Liquid biopsies and minimal residual disease in myeloid malignancies

in Hematologic Malignancies

Sabine Allam
Kristina Nasr
Farhan Khalid
Zunairah Shah
Mahammed Ziauddin Khan Suheb
Sana Mulla
Sindhu Vikash
Maroun Bou Zerdan
Faiz Anwer
Chakra P. Chaulagain

Frontiers in Oncology

doi 10.3389/fonc.2023.1164017

6,685 views
7 citations

Original Research

Published on 03 May 2023

Phase I study of intra-osseous co-transplantation of a single-unit cord blood and mesenchymal stromal cells with reduced intensity conditioning regimens

in Hematologic Malignancies

Jiasheng Wang
Farhad Sanati
Amin Firoozmand
Pingfu Fu
Merle Kolk
Jane Reese-Koc
Marcos de Lima
Kirsten Boughan
Brenda Cooper
Paolo Caimi

Frontiers in Oncology

doi 10.3389/fonc.2023.1186532

2,005 views
3 citations

Original Research

Published on 03 May 2023

The prognostic value of multiparametric cardiac magnetic resonance in patients with systemic light chain amyloidosis

in Hematologic Malignancies

Fujia Miao
Chunxiang Tang
Guisheng Ren
Jinzhou Guo
Liang Zhao
Weiwei Xu
Xiyang Zhou
Longjiang Zhang
Xianghua Huang

Frontiers in Oncology

doi 10.3389/fonc.2023.1069788

2,656 views
2 citations

Original Research

Published on 02 May 2023

Long-term outcomes of frontline imatinib therapy for chronic myeloid leukemia in China

in Hematologic Malignancies

Fang Cheng
Guolin Yuan
Qiang Li
Zheng Cui
Weiming Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1172910

4,773 views
13 citations

Original Research

Published on 02 May 2023

CD25 targeting with the afucosylated human IgG1 antibody RG6292 eliminates regulatory T cells and CD25+ blasts in acute myeloid leukemia

in Hematologic Malignancies

Laurène Pousse
Koorosh Korfi
Bruno C. Medeiros
Marco Berrera
Nadine Kumpesa
Jan Eckmann
Idil Karakoc Hutter
Vera Griesser
Vaios Karanikas
Christian Klein

Frontiers in Oncology

doi 10.3389/fonc.2023.1150149

17,347 views
9 citations

Case Report

Published on 01 May 2023

Case Report: Infectious prophylaxis in hematological malignancies

in Hematologic Malignancies

Mauro Passucci
Chiara Masucci
Francesca Paoletti
Claudia Ielo
Alessandro Costa
Ida Carmosino
Emilia Scalzulli
Maurizio Martelli
Giuseppe Gentile
Massimo Breccia

Frontiers in Oncology

doi 10.3389/fonc.2023.1163175

2,752 views
5 citations

Case Report

Published on 01 May 2023

B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB/c mouse: A case report

in Hematologic Malignancies

Sander Eens
Manon Van Hecke
Kasper Favere
Thomas Tousseyn
Pieter-Jan Guns
Tania Roskams
Hein Heidbuchel

Frontiers in Oncology

doi 10.3389/fonc.2023.1158124

165,756 views
12 citations

Review

Published on 28 Apr 2023

Challenges in nodal peripheral T-cell lymphomas: from biological advances to clinical applicability

in Hematologic Malignancies

Jasmine Zain
Avyakta Kallam

Frontiers in Oncology

doi 10.3389/fonc.2023.1150715

5,410 views
7 citations

Review

Published on 28 Apr 2023

Precise diagnosis and targeted therapy of nodal T-follicular helper cell lymphoma (T-FHCL)

in Hematologic Malignancies

Jun Du
Shikai Jin
Minghui Zhang
Xuehang Fu
Jingwen Yang
Liwen Zhang
Zhenwei Chen
Zoufang Huang
Weisong Li
Jian Hou

Frontiers in Oncology

doi 10.3389/fonc.2023.1163190

12,286 views
4 citations

Brief Research Report

Published on 28 Apr 2023

A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma

in Hematologic Malignancies

Adrián Mosquera Orgueira
Jose Ángel Díaz Arías
Rocio Serrano Martín
Victor Portela Piñeiro
Miguel Cid López
Andrés Peleteiro Raíndo
Laura Bao Pérez
Marta Sonia González Pérez
Manuel Mateo Pérez Encinas
Máximo Francisco Fraga Rodríguez

Frontiers in Oncology

doi 10.3389/fonc.2023.1157646

2,632 views
4 citations

2,056 articles

articles

A retrospective study of autologous hematopoietic stem cell transplantation for peripheral T-cell lymphoma: pre-transplant patients with partial remission benefit from post-transplant maintenance therapy

Clinical considerations at the intersection of hematopoietic cell transplantation and hereditary hematopoietic malignancy

Intragenic β-synuclein rearrangements in malignancy

Primary blastic plasmacytoid dendritic cell neoplasm: a US population-based study

Editorial: Acute leukemias: molecular characterization, leukemia-initiating cells, and influence of the microenvironment

Editorial: Measurable residual disease in hematologic malignancies

Effects of isolated central nervous system involvement evaluated by multiparameter flow cytometry prior to allografting on outcomes of patients with acute lymphoblastic leukemia

Preclinical investigations of the efficacy of the glutaminase inhibitor CB-839 alone and in combinations in chronic lymphocytic leukemia

Liquid biopsies and minimal residual disease in lymphoid malignancies

Gene mutation landscape of a rare patient with acute megakaryoblastic leukemia after treatment of intracranial germ cell tumor

The role of androgen therapy in acquired aplastic anemia and other bone marrow failure syndromes

Exploring preferences of different modes of administration of hypomethylating agent treatments among patients with acute myeloid leukemia

Case Report: First longitudinal study of a patient with CALR positive clonal hematopoiesis of indeterminate potential developing into pre-fibrotic myelofibrosis

Radiation doses to mediastinal organs at risk in early-stage unfavorable Hodgkin lymphoma– a risk stratified analysis of the GHSG HD17 trial

Liquid biopsies and minimal residual disease in myeloid malignancies

Phase I study of intra-osseous co-transplantation of a single-unit cord blood and mesenchymal stromal cells with reduced intensity conditioning regimens

The prognostic value of multiparametric cardiac magnetic resonance in patients with systemic light chain amyloidosis

Long-term outcomes of frontline imatinib therapy for chronic myeloid leukemia in China

CD25 targeting with the afucosylated human IgG1 antibody RG6292 eliminates regulatory T cells and CD25+ blasts in acute myeloid leukemia

Case Report: Infectious prophylaxis in hematological malignancies

B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB/c mouse: A case report

Challenges in nodal peripheral T-cell lymphomas: from biological advances to clinical applicability

Precise diagnosis and targeted therapy of nodal T-follicular helper cell lymphoma (T-FHCL)

A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma